Study on Herbal Medicines, Ascorbic Acid, Cyanocobalamin, Tenofovir, Treatment on HBeAg Positive or HBeAg Negative in Chronic Hepatitis B: A Combination of Treatment with Herbs

Abstract

In 2016, WHO’s World Health Assembly called for global elimination of viral hepatitis by 2030 and set global targets of achieving a 90% reduction in new cases of hepatitis B and hepatitis C, a 65% reduction in deaths from hepatitis B and hepatitis C, and treatment of 80% of people living with these infections. Individual countries are now in different stages of developing their own viral hepatitis elimination plans. The goal of antiviral therapy for hepatitis B is to reduce a patient's risks for progressive liver disease through prolonged suppression and eradication of HBV infection up to 100% limit and to arrest, ameliorate HBV-related liver damage. Phyllanthus urinaria, Adenosma Glutinosum, Eclipta Prostrata, Ascorbic Acid, Cyanocobalamin combination plus Tenofovir in treatment of acute and chronic hepatitis B. Method the combination of drugs derived from natural and artificial medicaments. This study has a stronger effect on the immune system, effective good against HBV replication. This is a substantial new insight into the pathogenesis of the disease, with a clear path toward clinical application, or which would lead to a substantial advance and perfect in management or public health policy. During the actual follow-up of this therapy being applied to patients for more than 10 years, the proposed research compound for the eradication of the hepatitis B virus has completed its assigned task.